SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-030609
Filing Date
2019-06-11
Accepted
2019-06-11 17:52:35
Documents
1
Period of Report
2019-06-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv523428_4.html 4  
1 OWNERSHIP DOCUMENT tv523428_4.xml 4 7878
  Complete submission text file 0001144204-19-030609.txt   9930
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5
Business Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5 416-213-4223
Lumira Capital Investment Management Inc. (Reporting) CIK: 0001702636 (see all company filings)

State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 19891957

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address
van der Velden Peter (Reporting) CIK: 0001778046 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 19891956